April 1, 2013
Dainippon Sumitomo Pharma (DSP) and Retina Institute Japan (RIJ; Fukuoka) announced an agreement on March 28 under which DSP will invest in RIJ and the two parties will discuss an alliance to commercialize induced pluripotent stem (iPS) cell technology for...read more